Today's D Brief: Austin, Blinken in Qatar; Panjshir resistance crushed?; ISI visits Taliban in Kabul; Pill for PTSD?; And a bit more.

SecDef Austin, SecState Blinken are in the Middle East today trying to negotiate a way home for the remaining U.S. citizens and Afghans fleeing Taliban control. One path forward could involve rolling back sanctions on Taliban officials in exchange for the safe passage of the two groups of travelers, the Wall Street Journal reports from Qatar, where “There are currently 4,000 Afghan evacuees,” after 41,000 or so have already travelled to the states. 

ICYMI: Qatar continues playing an outsized role in America’s extended departure from Afghanistan—from hosting negotiations with the Taliban in Doha under POTUS45, to helping with the evacuation efforts under POTUS46; and, of course, Qatar has hosted U.S. aircraft supporting regional combat operations going back to at least POTUS43.

But not so fast on any new international departures from Kabul, because no one’s leaving the country from that airport until the Taliban announce their government, group spokesman Zabiullah Mujahid reportedly said Tuesday, according to Khaama Press

BTW: Guess who became the first known foreign leader to visit the Taliban in Kabul? That would be Pakistani Inter-Services Intelligence chief, Lt. Gen. Faiz Hameed, who reportedly dropped by Afghanistan’s capital city on Saturday. 

Jokes the BBC's Paul Danahar: “As we prepare for the Taliban to seek new global alliances, it’s useful to remember that old proverb about Afghanistan’s warlords & rulers: ‘My enemy’s enemy’s friend’s enemy who was my friend is my enemy until he isn’t.’”

Taliban fighters violently broke up an anti-Pakistan protest led by women in Kabul today, the New York Times and Wall Street Journal report. The protests Tuesday were sparked by Hameed’s visit, and seem to have triggered escalating crowd control measures. Taliban special forces abruptly shut down an earlier protest by women in Kabul on Saturday, firing their weapons into the air to disperse the crowd, according to the Associated Press. On Tuesday, however, “They began beating protesters with rifle butts and sticks,” witnesses told the Times, “and the crowd scattered after the fighters began firing into the air.” Some of the protest organizers were detained, according to the Journal. Afghanistan’s Khaama Press carried video of the alleged incident in Kabul on Tuesday, shared via Twitter, here.

Developing: Afghanistan’s last pocket of resistance in Panjshir allegedly fell to the Taliban on Monday, CNN reported Monday. 

In bad omens, “basic services are collapsing” in Afghanistan, the U.N.’s Office for the Coordination of Humanitarian Affairs warned Tuesday from Geneva. OCHA officials issued an emergency appeal for $600 million to help the estimated 11 million people in need across the country. Read more at Ariana News.


From Defense One

The Defense Budget Process Is Broken // Daniel DePetris: What the U.S. needs isn’t more money for the Pentagon, but an honest and tough debate about strategy.

This May Be First Step In Curing PTSD With A Pill // Patrick Tucker: A start-up, funded in part by the U.S. Army, could be on track to revolutionizing what we know about PTSD.

Marines Ground All New Amphibious Vehicles // Caitlin M. Kenney: Tow-hook problem suspends all 54 ACVs.

US Marines Must Relearn to Protect Pacific Supply Lines, Commandant Says // Caitlin M. Kenney: As a backup, Berger says, troops must learn to “forage” for some supplies.

Italy’s Carabinieri Were the Perfect Force for the Kabul Evacuation // Elisabeth Braw: The soldier-policemen of this hybrid outfit went outside the wire to bring thousands to safety.

US Air Force’s First Software Chief Steps Down // Brandi Vincent: Nicolas Chaillan, who led a Pentagon-wide DevSecOps effort, said he was leaving in part because of a lack of support from senior leaders.

Welcome to this Tuesday edition of The D Brief from Ben Watson with Jennifer Hlad. If you’re not already subscribed to The D Brief, you can do that here


Vaxx litigation begins. Two staff sergeants have filed a lawsuit against the Defense Department, Department of Health and Human Services, and the Food and Drug Administration, challenging the mandate on COVID-19 vaccinations for troops, Army Times reports. The soldier and Marine, both based in North Carolina, say that troops who have had the virus already should not need the jab. Read more, here.

Did Raytheon pay Qatari military consultants almost $2 million in a veiled scheme intended for the royal family? That's what a dual U.S.-UK national named Tarek Fouad alleges, according to the Wall Street Journal, after a March 2015 contract “to advise on the acquisition of an advanced command-and-control system, dubbed the Falcon Project,” eventually collapsed about two years later. Fouad was one of three directors at the Doha-based consulting firm, Digital Soula Systems, which was formed in 2013, and is majority-owned by a brother of Qatar’s emir, Sheikh Joaan bin Hamad bin Khalifa Al Thani; another co-director alongside Fouad was an active duty lieutenant colonel in the Qatari armed forces.
According to Fouad, Raytheon paid DSS what was “supposed to be compensation for defense studies that Digital Soula Systems would produce for Raytheon...But metadata extracted from digital files of the studies appear to show that Raytheon itself had created them.”
The big problem: “Payments such as those alleged in Mr. Fouad’s lawsuit would have posed a serious [Foreign Corrupt Practices Act] risk for Raytheon, according to lawyers who reviewed the bribery allegations and documents from Mr. Fouad’s lawsuit.” Fouad’s lawsuit was dismissed in a U.S. district court last year; but the case has reportedly “led to inquiries by the U.S. Securities and Exchange Commission and the U.S. Justice Department.” Continue reading, here.

And lastly today: Can we cure PTSD with a pill? A new company with funding from the U.S. Army is looking into it, Defense One’s Science and Tech Editor Patrick Tucker reports.
The gist: “Dr. Jennifer Perusini, founder of Neurovation Labs, says PTSD has a unique biomarker called GluA1. It's a protein that is part of a glutamate receptor system, which helps memory formation. But trauma can also spur the creation of GluA1...Blocking the protein removed the anxiety, but the rats still displayed a healthy reaction to new frightening stimuli. That’s key, because it’s important to retain the ability to be scared by actual threats.” Read on, here.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.